RegMed Investors’ (RMi) closing bell: pick a move

June 19, 2018 6:00pm

The path is clear …

Hold, buy or sell – I recommend profiting in an uncertain and tentative market

Pre-open indications: 3 HITs and 1 MISS (1 by pennies and sold into end of session strength with profit). Right again as gene editing stocks - CRSP (-$0.57), NTLA ($0.00) fumbled even with patent award and EDIT (+$0.16) rose feebly after yesterday’s warning

Out and about: Stories of the day and a few of yesterday’s heroes – SLDB (+13.62 or +46.36%) jumps, CLBS (+$2.68 or +67.34%) on news, BSTG is also up on what (? - my opinion which scam Ponzi, pyramid or both) as ATHX (-$0.25) continues its decline

Of the 45 covered the 19 downside equities finished in a range of -$0.01 to -$1.61 with biggest bottoms of -$ and $ and $ while the 24 upside equities oscillated from +$0.04 to $1.78 with toppers of $13.62, $6.19, $4.00 and $3.55 with 2 flat closes

Let the analytics, trend lines, patterns and “count” speak - be a subscriber!  I’m also still waiting for someone else to have a daily view – RMi is it!

Henry’omics:

From the pre-open newsletter … “indications slump and dump. The iShares Nasdaq Biotechnology (IBB) is indicating a -1.29% downside in Tuesday’s pre-market. What goes overbought will come down and those left will go up when oversold. The times, they are a’changin!”

As I stated, “the overbought are getting riper even as the session reduced losses with low volume to the upside and higher volume to the downside.”

Tuesday’s theme for the session: seek cover of volume and strength; don’t SELL into a “sloppy” downside - advise well taken!

As the week progresses you've got to wonder how many equities are going to react to the current trend … as news helped the some of the largest upsides.

• It may all just be a game of bid’em up to the ultimate sell the overbought.

However, "with investor is fickle and most traders are NOT optimism while too many investors are non-compos mentis – in regard to the risk boundaries of miscalculation!

• Those real risks tend to be NOT measureable or can be calculated as to timing.

In one (1) research note, Caladrius Biosciences (CLBS) receives FDA’s RMAT designation for CD34+ for treating Refractory Angina … https://www.regmedinvestors.com/articles/10349

CLBS closed Monday at $3.95, opened at $4.15 and closed at $6.61 (+$2.66 or +67.34%) with 3.72 M shares traded <3 month average = 28.3 K shares> - I was wrong as the aftermarket also reflects an upside of $2.23 or +33.74% …

Athersys (ATHX) closed down -$0.25 to $2.06 after Monday’s $2.31 as June started at $2.52 and has slid since even with a partnership extension. Investors are TIRED as CEO collects more, more and more salary, benefits and perks – an untold numbers which are findable.

Pre-open indications:

• bluebird bio (BLUE) closed up +$1.15 – hit;
• Verastem Oncology (VSTM) closed up +$0.09 – miss;
• CRISPR (CRSP) closed down -$0.57 – hit;
• Editas (EDIT) closed up +$0.16 – miss;
• Intellia Therapeutics (NTLA) closed flat at $28.95 – hit;
• uniQure N.V. (QURE) closed up +$0.60 – miss;
• Solid Bioscience (SLDB) closed up +$13.62 – miss;

The advance/decline line scenario of 45 covered companies:   

• The open was negative with an A/DL of 16/24 and 5 flats;
• The mid-day continued negative with an A/DL of 18/27 and 0 flat;
• The close jumped positive with an A/DL of 24/19 and 2 flats;

MY working five (5) trend lines:

… The greatest volume to the downside:  ATHX, MDXG, CRSP, IONS and KOOL

… Upside volume was weighted to:  VSTM, SLDB, CLBS, SGMO and BMRN

… Biggest $ downside:  ALNY (-$1.61), SAGE (-$0.78), CRSP (-$0.57), BLCM (-$0.50) and MESO (-$0.26)

… Best moves to the $ upside: SLDB (+$13.62), ONCE (+$6.19), RENE.L (+$4.00), RGNX (+$3.55) and CLBS (+$2.66)

… Flats:  NTLA and STML

June sessions:

• Tuesday closed POSITIVE with 19 decliners, 24 advancers and 2 flat;
• Monday (June 18) closed NEGATIVE with 22 decliners, 20 advancers and 2 flat;
• Friday closed POSITIVE with 16 decliners, 23 advancers and 6 flat;
• Thursday closed POSITIVE with 18 decliners, 26 advancers and 1 flat;
• Wednesday closed POSITIVE with 20 decliners, 22 advancers and 3 flats;
• Tuesday closed POSITIVE with 17 decliners, 27 advancers and 1 flat;
• Monday (June 11) closed NEGATIVE with 26 decliners, 18 advancers and 1 flat;
• Friday closed NEUTRAL with 22 decliners, 22 advancers and 1 flat;
• Thursday closed NEGATIVE with 34 decliners, 9 advancers and 2 flat;
• Wednesday closed POSITIVE with 17 decliners, 24 advancers and 4 flat;
• Tuesday closed POSITIVE with 14 decliners, 30 advancers and 1 flat;
• Monday (June 4) closed POSITIVE with 18 decliners, 25 advancers and 2 flat;
• Friday (June 1) closed was POSITIVE with 15 decliners, 29 advancers and 1 flat;

Daily analytics – notice the patterns:

• The Dow fell 287.26 points to close at 24,700.21.
• The S&P 500 dropped 0.4%to 2,762.45.
• The NASDAQ closed down -0.3% at 7,725.59.

The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market,

• Tuesday traded at 13.35, up +8.45%
• Monday traded at 12.31, up +2.75%
• Friday traded at 11.95, down -1.40%
• Thursday traded at 12.12, down -6.34 %
• Wednesday traded at 12.94, up +4.86%
• Last Tuesday traded at 12.34, down -0.08%

The iShares Russell 2000 (IWM) closed:

• Tuesday was up +0.04%;
• Monday was up +0.48%;
• Friday was down -0.04%;
• Thursday was up +0.54%;
• Wednesday was down -0.36%;
• Last Tuesday was up +0.44%;

The iShares NASDAQ Biotechnology (IBB) closed:

• Tuesday was up +1.46%
• Monday was down -0.75%
• Friday was down -0.11%
• Thursday was up +0.81%
• Wednesday was down -0.38%
• Last Tuesday was up +0.85%

The count in June - decliners versus gainers:

……. look at the differences in decliners:

• Tuesday’s decliners ranged from -1.52% <ALNY -$1.61 > to -0.23% <BCLI -$0.01 > in 19 equities;
• Monday’s decliners ranged from -0.28% <STML -$0.05 > to -9.47% <BLCM -$0.94 > in 22 equities;
• Friday’s decliners ranged from -0.32% < VYGR -$0.07> to -15.95% < CUR -$0.26> in 16 equities;
• Thursday’s decliners ranged from -0.43% <ATHX -$0.01 > to -5.41% <VCEL -$0.70 > in 18 equities;
• Wednesday’s decliners ranged from -0.03% < CLLS -$0.01> to -7.41% <MDXG -$0.44) > in 20 equities;
• Last Tuesday’s decliners ranged from -0.18% <RGNX -$0.10> to -7.71% <KOOL -$0.042 > in 17 equities;

Versus

… Look at the percentage’s (%) and spreads …

• Tuesday’s gainers ranged from +0.04% <BMRN +$0.04 > to +46.36% <SLDB +$13.62 > in 24 equities;
• Monday’s gainers ranged from +0.43% <BTX +$0.01 > to +31.39% <VSTM +$2.05 > in 20 equities;
• Friday’s gainers ranged from +0.06% <SAGE +$0.10 > to +17.03% < VSTM +$0.95> in 23 equities;
• Thursday’s gainers ranged from +0.10% < BOLD +$0.04> to +8.45% <ADRO +$0.60 > in 26 equities;
• Wednesday’s gainers ranged from +0.03% <BOLD +$0.01> to +12% <BSTG +$0.45 > in 22 equities;
• Last Tuesday’s gainers ranged from +0.03% <BOLD +$0-.01> to +29.31% <BSTG +$0.85 > in 27 equities;

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.